Cantor Fitzgerald reiterated their coverage. Sell! They have been continuously wrong about sgen. I guess at least they are consistent.
Not picking on you but "reiteration" is not a downgrade.
The fact that they are reiterating a sell is still a negative tho.
From Twitter: Credit Suisse move $SGEN's PT to $46 from $40. Said to expect good data at ASH.